Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, Texas.
Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
Cancer Immunol Res. 2018 Jan;6(1):47-58. doi: 10.1158/2326-6066.CIR-17-0126. Epub 2017 Oct 27.
T cells expressing second-generation chimeric antigen receptors (CARs) specific for CD5, a T-cell surface marker present on normal and malignant T cells, can selectively kill tumor cells. We aimed to improve this killing by substituting the CD28 costimulatory endodomain (28.z) with 4-1BB (BB.z), as 28.z CD5 CAR T cells rapidly differentiated into short-lived effector cells. In contrast, 4-1BB costimulation is known to promote development of the central memory subpopulation. Here, we found BB.z CD5 CAR T cells had impaired growth compared with 28.z CD5.CAR T cells, due to increased T-cell-T-cell fratricide. We demonstrate that TRAF signaling from the 4-1BB endodomain upregulated the intercellular adhesion molecule 1, which stabilized the fratricidal immunologic synapse between CD5 CAR T cells. As the surviving BB.z CD5 CAR T cells retained the desired central memory phenotype, we aimed to circumvent the 4-1BB-mediated toxicity using a regulated expression system that reversibly inhibits CAR expression. This system minimized CAR signaling and T-cell fratricide during expansion in the presence of a small-molecule inhibitor, and restored CAR expression and antitumor function of transduced T cells These studies reveal a mechanism by which 4-1BB costimulation impairs expansion of CD5 CAR T cells and offer a solution to mitigate this toxicity. .
表达第二代嵌合抗原受体(CAR)的 T 细胞特异性针对 CD5,这是一种存在于正常和恶性 T 细胞表面的 T 细胞表面标志物,能够选择性地杀伤肿瘤细胞。我们旨在通过用 4-1BB(BB.z)替代 CD28 共刺激内源性结构域(28.z)来改善这种杀伤作用,因为 28.z CD5 CAR T 细胞迅速分化为短暂存活的效应细胞。相比之下,4-1BB 共刺激作用已知可促进中央记忆亚群的发育。在这里,我们发现 BB.z CD5 CAR T 细胞的生长能力比 28.z CD5.CAR T 细胞受损,这是由于 T 细胞之间的自噬增加所致。我们证明,来自 4-1BB 内源性结构域的 TRAF 信号转导上调了细胞间黏附分子 1,从而稳定了 CD5 CAR T 细胞之间的自噬性免疫突触。由于存活的 BB.z CD5 CAR T 细胞保留了所需的中央记忆表型,我们旨在使用可调节表达系统来规避 4-1BB 介导的毒性,该系统可在小分子抑制剂存在的情况下可逆地抑制 CAR 表达。该系统在扩展过程中最大限度地减少了 CAR 信号和 T 细胞自噬,恢复了转导 T 细胞的 CAR 表达和抗肿瘤功能。这些研究揭示了 4-1BB 共刺激作用如何损害 CD5 CAR T 细胞的扩增,并提供了一种减轻这种毒性的解决方案。
Cancer Immunol Res. 2017-11-27
JCI Insight. 2018-9-20
Cancers (Basel). 2024-10-15
Nat Med. 2024-12
Sci Immunol. 2024-7-19
J Hematol Oncol. 2024-6-24
Haematologica. 2024-6-1
Front Oncol. 2024-4-22
J Clin Invest. 2016-6-1
N Engl J Med. 2014-10-16